EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Persistent Corneal Epithelial Defects by Autologous Serum



Treatment of Persistent Corneal Epithelial Defects by Autologous Serum



ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1693



Purpose: To assess the efficacy of autologous serum for the treatment of persistent epithelial defects. Method: Patients suffering from persistent epithelial defects were treated with autologous serum. Serum was diluted to 20% by saline. Patients were asked to use it 3 to 6 times a day for 2 months. Tear dynamics were evaluated with Schirmer test and ocular surface status was assessed by fluorescein vital staining. Impression cytologies were performed before and after the treatment. Results: A total of 18 patients were included : 12 were postcorneal transplant patients, 3 had postherpetic keratitis, one had an epikeratophakia and two had alkali burns. Schirmer test results remained unchanged but the vital staining showed a significant improvement after 2 months (p<0.05). Conversely, impression cytology analyses did not show any difference before and after treatment. Conclusion: Persistent epithelial defects have several origins. Neurotrophic problems are important factors in ocular surface diseases. The efficacy of autologous serum is probably due to its vitamin compensation but perhaps to its neuropeptide supply. Autologous serum is an interesting tool for the treatment of persistent epithelial defects.

(PDF 0-2 workdays service: $29.90)

Accession: 035980570

Download citation: RISBibTeXText



Related references

Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea 28(10): 1104-1108, 2010

Autologous serum eye drops for the treatment of persistent corneal epithelial defects. Journal of the College of Physicians and Surgeons--Pakistan 23(10): 737-739, 2014

Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Der Ophthalmologe 101(7): 705-709, 2004

Treatment of Persistent Corneal Epithelial Defects After Vitreoretinal Surgery: Autologous Serum Eye Drops or a Bandage Contact Lens?. Cornea 27(9): 1097-1098, 2008

Autologous Serum Eye Drops Combined With Silicone Hydrogen Lenses for the Treatment of Postinfectious Corneal Persistent Epithelial Defects. Eye & Contact Lens (): -, 2016

The use of autologous serum tears in persistent corneal epithelial defects. Eye (Basingstoke) 18(6): 609-614, June, 2004

Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study. Contact Lens & Anterior Eye 39(6): 425-430, 2016

Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10): 1984-1989, 1999

Treatment of persistent epithelial defects using autologous serum application. Archivos de la Sociedad Espanola de Oftalmologia 79(11): 537-542, 2004

Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects. Eye & Contact Lens 37(6): 370-373, 2012

Role of autologous serum in persistent epithelial defects. British Journal of Ophthalmology 86(7): 832-832, 2002

Topical fibronectin treatment in persistent corneal epithelial defects and corneal ulcers. Korean Journal of Ophthalmology 4(1): 5-11, 1990

Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea 24(8): 992-997, 2005

Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery. Cornea 27(9): 1097; Author Reply 1097-8, 2008

Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. British Journal of Ophthalmology 87(11): 1312-1316, 2003